In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on Strata Skin Sciences Inc (SSKN), with a price target of $7. The company’s shares closed on Friday at $2.85.
According to TipRanks.com, Kalia is a 5-star analyst with an average return of 8.7% and a 53.2% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Obalon Therapeutics Inc, and Apollo Endosurgery Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Strata Skin Sciences Inc with a $6 average price target.
See today’s analyst top recommended stocks >>
Based on Strata Skin Sciences Inc’s latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $290K. In comparison, last year the company had a GAAP net loss of $13.67 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
STRATA Skin Sciences, Inc. is a medical technology company, which engages in the design, development, and commercializing of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
